181 related articles for article (PubMed ID: 31872963)
21. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
[TBL] [Abstract][Full Text] [Related]
22. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG
Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276
[TBL] [Abstract][Full Text] [Related]
27. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract][Full Text] [Related]
28. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
29. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dean DC; Shen S; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
[TBL] [Abstract][Full Text] [Related]
30. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
Watson NF; Durrant LG; Scholefield JH; Madjd Z; Scrimgeour D; Spendlove I; Ellis IO; Patel PM
World J Gastroenterol; 2006 Oct; 12(39):6299-304. PubMed ID: 17072952
[TBL] [Abstract][Full Text] [Related]
32. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.
Teng Y; Hu L; Yu B; Li X; Chen M; Fu X; Zhang J; Gao Y; Xu R; Zhu J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):336-344. PubMed ID: 31884829
[TBL] [Abstract][Full Text] [Related]
34. CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome.
Gvozdenovic A; Arlt MJ; Campanile C; Brennecke P; Husmann K; Li Y; Born W; Muff R; Fuchs B
J Bone Miner Res; 2013 Apr; 28(4):838-47. PubMed ID: 23169460
[TBL] [Abstract][Full Text] [Related]
35. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-492 overexpression exerts suppressive effects on the progression of osteosarcoma by targeting PAK7.
Song X; Xie Y; Liu Y; Shao M; Yang W
Int J Mol Med; 2017 Sep; 40(3):891-897. PubMed ID: 28677719
[TBL] [Abstract][Full Text] [Related]
37. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.
Kfir S; Ehrlich M; Goldshmid A; Liu X; Kloog Y; Henis YI
Mol Cell Biol; 2005 Sep; 25(18):8239-50. PubMed ID: 16135812
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
40. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
